Humana (HUM) Holder Equitec Proprietary Markets Has Increased Its Stake by $2.60 Million; Bloombergsen Raised Holding in Oracle (ORCL) as Stock Declined

June 18, 2018 - By Neil V. Hobbs

Oracle Corporation (NYSE:ORCL) Logo

Bloombergsen Inc increased its stake in Oracle Corp (ORCL) by 44.22% based on its latest 2018Q1 regulatory filing with the SEC. Bloombergsen Inc bought 601,404 shares as the company’s stock declined 8.15% with the market. The institutional investor held 1.96M shares of the prepackaged software company at the end of 2018Q1, valued at $89.76 million, up from 1.36M at the end of the previous reported quarter. Bloombergsen Inc who had been investing in Oracle Corp for a number of months, seems to be bullish on the $186.70 billion market cap company. The stock decreased 1.18% or $0.545 during the last trading session, reaching $45.735. About 937,185 shares traded. Oracle Corporation (NYSE:ORCL) has risen 3.98% since June 18, 2017 and is uptrending. It has underperformed by 8.59% the S&P500. Some Historical ORCL News: 18/05/2018 – Oracle Blockchain Cloud Service and Financial Services Enable Next-Gen Blockchain Innovators; 05/04/2018 – Mercury News: Oracle CEO Safra Catz raises Amazon cloud contract fight with Trump; 19/03/2018 – Oracle 3Q Loss/Shr 98c; 25/04/2018 – Determine, Inc., a Top-Ranked Source-to-Pay Innovator, Puts State-of-the-Art Cloud Platform on Display at ISM2018; 14/03/2018 – Oracle to Break Down the Barriers to Creating Epic Customer Experiences at Modern Customer Experience 2018; 14/05/2018 – JTB Corporation adopts Oracle Cloud for Its International Travel Processing System Infrastructure; 19/03/2018 – ORACLE CORP QTRLY CLOUD PLATFORM AS A SERVICE (PAAS) PLUS INFRASTRUCTURE AS A SERVICE (IAAS) REVENUES WERE UP 28% TO $415 MLN; 13/04/2018 – ORACLE IS SAID TO LEAD ANTI-AMAZON LOBBY ON PENTAGON CLOUD BID; 27/03/2018 – ORACLE CAN SEEK BILLIONS FROM GOOGLE OVER USE OF ANDROID; 20/03/2018 – EXCLUSIVE-Salesforce in advanced talks to buy MuleSoft

Equitec Proprietary Markets Llc increased its stake in Humana Inc (HUM) by 118.29% based on its latest 2018Q1 regulatory filing with the SEC. Equitec Proprietary Markets Llc bought 9,700 shares as the company’s stock rose 7.22% while stock markets declined. The institutional investor held 17,900 shares of the medical specialities company at the end of 2018Q1, valued at $4.81 million, up from 8,200 at the end of the previous reported quarter. Equitec Proprietary Markets Llc who had been investing in Humana Inc for a number of months, seems to be bullish on the $42.25B market cap company. The stock decreased 0.02% or $0.065 during the last trading session, reaching $306.885. About 16,670 shares traded. Humana Inc. (NYSE:HUM) has risen 26.78% since June 18, 2017 and is uptrending. It has outperformed by 14.21% the S&P500. Some Historical HUM News: 02/04/2018 – Humana Closes Above 50-Day Moving Average: Technicals; 02/04/2018 – Deals of the day-Mergers and acquisitions; 18/04/2018 – Humana Launches National Value-Based Model for Maternity Care; 02/05/2018 – SPGR Lowers Humana Health Plans of PR Rtgs To ‘B-‘; On CW Neg; 23/04/2018 – Moody’s places Curo’s ratings under review – direction uncertain following announced acquisition; 10/04/2018 – Humana Presenting at Deutsche Bank Health Care Conference May 8; 23/04/2018 – Humana-Led Group to Buy Hospice Operator in $1.4 Billion Deal; 02/05/2018 – Humana Raises 2019 View To EPS $13.54-EPS $13.94; 02/05/2018 – HUMANA REPORTS 1Q 2018 FINL RESULTS; RAISES FULL YEAR 2018 EPS; 10/04/2018 – HUMANA: DEAL NOT TO HAVE MATERIAL IMPACT ON 2018 GUIDANCE

Equitec Proprietary Markets Llc, which manages about $327.49 million US Long portfolio, decreased its stake in Ikang Healthcare Group Inc (Call) (NASDAQ:KANG) by 98,900 shares to 25,600 shares, valued at $511,000 in 2018Q1, according to the filing. It also reduced its holding in Intrexon Corp (Put) (NYSE:XON) by 53,900 shares in the quarter, leaving it with 29,800 shares, and cut its stake in General Electric Co (NYSE:GE).

More important recent Humana Inc. (NYSE:HUM) news were published by: Bizjournals.com which released: “Humana faces anti-kickback, False Claims Act suit over diabetes testing equipment” on June 12, 2018, also Bizjournals.com published article titled: “Humana tries to block release of ‘trade secrets’ by federal agency”, Bizjournals.com published: “Humana exec offloads millions in company stock” on June 05, 2018. More interesting news about Humana Inc. (NYSE:HUM) was released by: Globenewswire.com and their article: “Consolidated Research: 2018 Summary Expectations for Humana, DexCom, Royal Dutch Shell, First Connecticut …” with publication date: June 14, 2018.

Investors sentiment decreased to 0.78 in 2018 Q1. Its down 0.27, from 1.05 in 2017Q4. It worsened, as 48 investors sold HUM shares while 233 reduced holdings. 53 funds opened positions while 165 raised stakes. 122.28 million shares or 2.59% less from 125.53 million shares in 2017Q4 were reported. Parkside Fincl Bank & Tru owns 78 shares. Shell Asset Mgmt Company has 11,100 shares for 0.06% of their portfolio. Atria Investments Limited Liability Co owns 5,564 shares for 0.07% of their portfolio. 2,040 were accumulated by Meiji Yasuda Life Company. Bbva Compass National Bank, a Texas-based fund reported 1,369 shares. Clinton reported 25,325 shares. Atlantic Trust Gru Limited Liability Corp has 0.07% invested in Humana Inc. (NYSE:HUM). The Connecticut-based Mark Sheptoff Financial Planning Limited Liability has invested 0% in Humana Inc. (NYSE:HUM). Pinebridge Ltd Partnership holds 0.04% or 5,988 shares in its portfolio. Vanguard Grp Inc Inc has invested 0.12% in Humana Inc. (NYSE:HUM). Moreover, Caisse De Depot Et Placement Du Quebec has 0.11% invested in Humana Inc. (NYSE:HUM) for 175,200 shares. Mckinley Capital Limited Co Delaware reported 122,438 shares. First Commonwealth Fincl Pa stated it has 1.15% in Humana Inc. (NYSE:HUM). Legg Mason Asset Management (Japan) holds 0.68% or 3,600 shares in its portfolio. Sumitomo Mitsui Asset Mngmt Limited holds 0.04% of its portfolio in Humana Inc. (NYSE:HUM) for 10,225 shares.

Since February 24, 2018, it had 0 insider purchases, and 13 sales for $36.37 million activity. On Saturday, February 24 the insider LeClaire Brian P. sold $3.49 million. On Saturday, February 24 the insider Huval Timothy S. sold $4.45 million. 17,604 shares valued at $5.04M were sold by BROUSSARD BRUCE D on Thursday, May 3. On Monday, June 4 the insider Fleming William Kevin sold $4.58M. Another trade for 1,000 shares valued at $306,005 was made by Zipperle Cynthia H on Wednesday, June 13. The insider BILNEY JODY L sold $801,477.

Among 23 analysts covering Humana (NYSE:HUM), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Humana had 82 analyst reports since July 30, 2015 according to SRatingsIntel. RBC Capital Markets maintained it with “Hold” rating and $242.0 target in Thursday, November 9 report. The stock of Humana Inc. (NYSE:HUM) earned “Sector Perform” rating by RBC Capital Markets on Tuesday, September 8. The stock of Humana Inc. (NYSE:HUM) has “Buy” rating given on Monday, November 27 by Leerink Swann. The stock of Humana Inc. (NYSE:HUM) has “Buy” rating given on Friday, September 23 by Evercore. Oppenheimer maintained the stock with “Outperform” rating in Thursday, March 30 report. The stock of Humana Inc. (NYSE:HUM) has “Neutral” rating given on Tuesday, April 11 by Cantor Fitzgerald. Piper Jaffray maintained the stock with “Buy” rating in Wednesday, February 7 report. Cantor Fitzgerald maintained Humana Inc. (NYSE:HUM) on Wednesday, February 7 with “Hold” rating. The rating was maintained by Credit Suisse on Friday, November 10 with “Neutral”. Deutsche Bank maintained the stock with “Hold” rating in Monday, August 7 report.

Among 43 analysts covering Oracle (NYSE:ORCL), 26 have Buy rating, 0 Sell and 17 Hold. Therefore 60% are positive. Oracle had 118 analyst reports since July 30, 2015 according to SRatingsIntel. On Monday, September 11 the stock rating was maintained by Cowen & Co with “Buy”. The firm earned “Buy” rating on Monday, July 24 by Stifel Nicolaus. KeyBanc Capital Markets upgraded the stock to “Overweight” rating in Wednesday, July 5 report. On Wednesday, January 11 the stock rating was initiated by Wells Fargo with “Outperform”. The firm has “Hold” rating given on Tuesday, March 20 by Stifel Nicolaus. The firm has “Buy” rating by Stifel Nicolaus given on Sunday, September 10. The stock of Oracle Corporation (NYSE:ORCL) earned “Buy” rating by Benchmark on Friday, April 28. The rating was maintained by UBS on Thursday, December 17 with “Buy”. BMO Capital Markets maintained the shares of ORCL in report on Wednesday, August 16 with “Buy” rating. The stock of Oracle Corporation (NYSE:ORCL) earned “Buy” rating by Stifel Nicolaus on Thursday, September 17.

More notable recent Oracle Corporation (NYSE:ORCL) news were published by: Seekingalpha.com which released: “The Information: Oracle’s aggressive cloud sales tactics push away customers” on May 22, 2018, also Seekingalpha.com with their article: “Oracle -2.5% as JP Morgan steps to sidelines, Nomura lowers target” published on June 14, 2018, Streetinsider.com published: “Oracle (ORCL) PT Lowered to $52 at Piper Jaffray; Checks Suggest In-Line Qtr” on June 18, 2018. More interesting news about Oracle Corporation (NYSE:ORCL) were released by: Streetinsider.com and their article: “Oracle (ORCL) PT Lowered to $51 at BofA/Merrill Lynch” published on June 18, 2018 as well as Seekingalpha.com‘s news article titled: “Oracle: Buy While Expectations Are Low” with publication date: June 18, 2018.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.